ID: ALA5196008

Max Phase: Preclinical

Molecular Formula: C34H54ClNO9

Molecular Weight: 656.26

Associated Items:

Representations

Canonical SMILES:  CC(/C=C/[C@H]1O[C@H](CC(=O)OC(C)(C)C)C[C@@](O)(CCl)[C@@H]1O)=C\C[C@@H]1O[C@H](C)[C@H](NC(=O)/C=C\[C@H](C)OC(=O)C(C)C)C[C@@H]1C

Standard InChI:  InChI=1S/C34H54ClNO9/c1-20(2)32(40)42-23(5)12-15-29(37)36-26-16-22(4)27(43-24(26)6)13-10-21(3)11-14-28-31(39)34(41,19-35)18-25(44-28)17-30(38)45-33(7,8)9/h10-12,14-15,20,22-28,31,39,41H,13,16-19H2,1-9H3,(H,36,37)/b14-11+,15-12-,21-10+/t22-,23-,24+,25+,26+,27-,28+,31+,34+/m0/s1

Standard InChI Key:  VTMHGNWAKMAYIP-ZIVTWHCVSA-N

Associated Targets(Human)

MES-SA/Dx5 643 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MES-SA 905 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HEK-293T 167025 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 656.26Molecular Weight (Monoisotopic): 655.3487AlogP: 4.54#Rotatable Bonds: 12
Polar Surface Area: 140.62Molecular Species: NEUTRALHBA: 9HBD: 3
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.64CX Basic pKa: CX LogP: 4.21CX LogD: 4.21
Aromatic Rings: 0Heavy Atoms: 45QED Weighted: 0.12Np Likeness Score: 2.04

References

1. Ghosh AK, Mishevich JL, Jurica MS..  (2021)  Spliceostatins and Derivatives: Chemical Syntheses and Biological Properties of Potent Splicing Inhibitors.,  84  (5.0): [PMID:33974423] [10.1021/acs.jnatprod.1c00100]

Source